MK-4646 Multiple Dose Trial in Participants with human immunodeficiency virus type 1 (HIV-1) (MK-4646-003)

Trial Identifier:	4646-003
Sponsor:	MSD
Start Date:	July 2025
Primary Completion Date:	July 2026
Study Completion Date:	August 2026
Condition:	Human Immunodeficiency Virus (HIV)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	Protocol Plain Language Summary

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Moldova, Republic of, Chisinau	Chisinau, Moldova, Republic of, 2025
Romania, Bucuresti	București, Bucuresti, Romania, 021105

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.